MedPath

Human Use Condition Study- Evaluation of Implanted Leads in Humans

Completed
Conditions
Pacemaker Malfunction
Registration Number
NCT04320849
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to evaluate different types of leads (wires) that are connected to your pacemaker (an implanted device which assists your heart function) to understand how the shape and motion of your previously implanted lead changes in the body.

Detailed Description

The purpose of this study is to evaluate different types of leads (wires) that are connected to the pacemaker (an implanted device which assists enrolled subject's heart function) to understand how the shape and motion of the previously implanted lead changes in the body.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
117
Inclusion Criteria

Patients with RV leads included in the scope of this study whose system has been implanted for at least 3 calendar months Patients at least 18 years of age and capable of providing informed consent Patients who can physically perform range of arm motion and breath-holding described in the imaging protocol Patients who are willing and able to comply with instruction related to the imaging protocol

Read More
Exclusion Criteria

Planned lead modification Patients with abandoned leads (includes: RV/RA/LV) Patients undergoing second or subsequent pulse generator change Patient has permanent atrial arrhythmias Limited life expectancy or medical condition that would not allow completion of the study Patient is known to be pregnant or breastfeeding at time of consent Limited range of mobility of the implant location arm Patient is unable to climb on and off an examination table unassisted Patients deemed hemodynamically unstable

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Participants With in Vivo Cyclic Mean Curvature of Pacing and Defibrillation Leads in the Extravenous Region Determined During Specified Arm MovementsApproximately 1 month

Measure dynamic in vivo curvature of RV pacing and defibrillator leads in the extravenous and intracardiac anatomy

\*\*\*In vivo cyclic mean curvature of RV pacing and defibrillation leads in the extravenous region will be determined during specified arm movements. The relationship between lead stiffness and curvature will be evaluated.

Number of Participants With in Vivo Cyclic Mean Curvature of Pacing and Defibrillation Leads in the Connector Region Determined During Specified Arm MovementsApproximately 1 month

Assess the relationship between subject and implant variables and lead curvature

\*\*\*In vivo cyclic mean curvature of RV pacing and defibrillation leads in the connector region were determined during specified arm movements. The relationship between lead stiffness and curvature was evaluated.

Number of Participants With in Vivo Cyclic Mean Curvature of Pacing and Defibrillation Leads in the Intracardiac Region Determined During Two or More Cardiac CyclesApproximately 1 month

Measure the relationship between lead bending stiffness and in vivo curvature

\*\*\*In vivo cyclic mean curvature of RV pacing and defibrillation leads in the intracardiac region will be determined during two or more cardiac cycles. The relationship between lead stiffness and curvature will be evaluated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Jackson Heart Clinic

🇺🇸

Jackson, Mississippi, United States

Trinity Clinic

🇺🇸

Tyler, Texas, United States

Minneapolis Heart Institute

🇺🇸

Saint Paul, Minnesota, United States

MercyOne Iowa Heart Center

🇺🇸

Des Moines, Iowa, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath